Please join AGG Healthcare and Life Sciences partners for a timely webinar exploring government enforcement risks affecting the life sciences industry. Drawing from their experience as former government attorneys, the panelists will offer their perspectives on how life sciences companies can prepare for emerging compliance challenges and litigation trends.
This program is the first installment in AGG’s new “Line of Cite” webinar series, which features AGG’s team of former government attorneys speaking on current developments and enforcement updates across their respective agencies, including the DOJ and HHS.
Topics
- Evolving Compliance Issues in the Patient Support Services and Reimbursement Space
- Emerging Criminal and Civil Enforcement Trends Under the FDCA: Gender-Affirming Care, Counterfeits, and the Reorganization of CPB
- Reading the Tea Leaves on the Administration’s Priorities and the FCA Working Group
- Step Therapy in Medicare Advantage — Can It Survive Judicial Scrutiny Post-Chevron?
Speakers
- David Blank, Former Senior Counsel at the Office of Inspector General, U.S. Department of Health and Human Services
- Gabe Scannapieco, Former Assistant Director at the U.S. Department of Justice Consumer Protection Branch
- Brian Stimson, Former Acting General Counsel and Principal Deputy General Counsel of the U.S. Department of Health and Human Services
- Andrew Tsui, Former Litigation Counsel at the U.S. Department of Health and Human Services, Office of the General Counsel, Centers for Medicare & Medicaid Services Division
Moderator
There will be an opportunity for Q&A at the end of this webinar.
Credits: 1 hour of CLE credit has been approved by the State Bar of Georgia.